Ann: Ethics Approval for BTX 1308 Psoriasis Patient Study Secured, page-98

Yes, ACW, IMU and DXB have stated they are in constant discussions with several interested parties , ACW released Interim Phase II trial results and had Bioinvest fund come in with $15m for phase III testing. IMU have stated they do not intend to cross the line with ownership of the Technology and upon completion have several interested parties as they are aware of the market segment value 2.2B.

All very well for BOT to say we are taking this through Phase II but as we are in Phase II whats the outcome of Positive results?? whos waiting??

PAA are the the only Biotech I know of that have a complete Global Distribution deal by Mega Pharma on completion , they have an agreement with Elanco who just got spun off Eli Liily for $3B... as you approach the commercial end of the Product/Treatment development you have to inform investors whats on the Horizon,,, BOT have been focused on Phase II but its time to inform the Market,,how big is this pot of gold at the end of the Rainbow and who are the leprechauns with the cheque book